These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 11477459)

  • 1. (E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells.
    Hamel W; Zirkel D; Mehdorn HM; Westphal M; Israel MA
    Cancer Gene Ther; 2001 May; 8(5):388-96. PubMed ID: 11477459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Seno T
    Mol Pharmacol; 1985 Dec; 28(6):581-7. PubMed ID: 3001499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy.
    Frank S; Steffens S; Fischer U; Tlolko A; Rainov NG; Kramm CM
    Cancer Gene Ther; 2002 Feb; 9(2):178-88. PubMed ID: 11857036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of HSV-1 TK gene-transfected murine mammary carcinoma cells resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and ganciclovir (GCV).
    Degrève B; De Clercq E; Balzarini J
    Gene Ther; 2000 Sep; 7(18):1543-52. PubMed ID: 11021592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme prodrug gene therapy: synergistic use of the herpes simplex virus-cellular thymidine kinase/ganciclovir system and thymidylate synthase inhibitors for the treatment of colon cancer.
    Wildner O; Blaese RM; Candotti F
    Cancer Res; 1999 Oct; 59(20):5233-8. PubMed ID: 10537302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.
    Grignet-Debrus C; Cool V; Baudson N; Degrève B; Balzarini J; De Leval L; Debrus S; Velu T; Calberg-Bacq CM
    Cancer Gene Ther; 2000 Feb; 7(2):215-23. PubMed ID: 10770629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytoxicity by hydroxyurea.
    Boucher PD; Ostruszka LJ; Shewach DS
    Cancer Res; 2000 Mar; 60(6):1631-6. PubMed ID: 10749133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
    Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of ganciclovir toxicity in the herpes simplex virus thymidine kinase/ganciclovir administration system by ponicidin.
    Hayashi K; Hayashi T; Sun HD; Takeda Y
    Cancer Gene Ther; 2000 Jan; 7(1):45-52. PubMed ID: 10678355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
    Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D
    Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
    Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbocyclic 5-iodo-2'-deoxyuridine (C-IDU) and carbocyclic (E)-5-(2-bromovinyl)-2'-deoxyuridine (C-BVDU) as unique examples of chiral molecules where the two enantiomeric forms are biologically active: interaction of the (+)- and (-)-enantiomers of C-IDU and C-BVDU with the thymidine kinase of herpes simplex virus type 1.
    Balzarini J; De Clercq E; Baumgartner H; Bodenteich M; Griengl H
    Mol Pharmacol; 1990 Mar; 37(3):395-401. PubMed ID: 2156153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells.
    Balzarini J; Bohman C; Walker RT; de Clercq E
    Mol Pharmacol; 1994 Jun; 45(6):1253-8. PubMed ID: 8022417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
    Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
    Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCR-ABL-expressing cells transduced with the HSV-tk gene die by apoptosis upon treatment with ganciclovir.
    Rivas C; Miller AR; Collado M; Lam EW; Apperley JF; Melo JV
    Mol Ther; 2001 May; 3(5 Pt 1):642-52. PubMed ID: 11356068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connexin-independent ganciclovir-mediated killing conferred on bystander effect-resistant cell lines by a herpes simplex virus-thymidine kinase-expressing colon cell line.
    Drake RR; Pitlyk K; McMasters RA; Mercer KE; Young H; Moyer MP
    Mol Ther; 2000 Nov; 2(5):515-23. PubMed ID: 11082325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity and accumulation of ganciclovir triphosphate in bystander cells cocultured with herpes simplex virus type 1 thymidine kinase-expressing human glioblastoma cells.
    Rubsam LZ; Boucher PD; Murphy PJ; KuKuruga M; Shewach DS
    Cancer Res; 1999 Feb; 59(3):669-75. PubMed ID: 9973216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir.
    Rosenfeld ME; Feng M; Michael SI; Siegal GP; Alvarez RD; Curiel DT
    Clin Cancer Res; 1995 Dec; 1(12):1571-80. PubMed ID: 9815958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.